← Leaderboards
Sigmund E. Lasker
Lambda Associates, Inc.
$263,324
Attributed
$263,324
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $149.9K · FY2008–10$200K$150K$100K$50K$0
'08
'09
'10
Funding mix
By agency
NIH$263,324 · 2
By mechanism
R43$263,324 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Anticoagulants”
- Walter N Kernan · Yale University$42,197,025
- John H Griffin · Scripps Research Institute$30,205,671
- Thomas L Ortel · Duke University$24,081,156
- Shunichi Homma · Columbia University Health Sciences$22,614,584
- Oscar R Benavente · University Of Texas Hlth Sci Ctr San Ant$22,554,960
- Erik Ian Tucker · Aronora, Inc.$21,529,628
Research focus
AnticoagulantsHeparinBloodFibrinolytic AgentsDoseHemorrhageEconomicsCholic AcidsAnimalsBiological AvailabilityBaseCarboxyl GroupCardiovascular SystemAnticoagulant TherapyFeasibility StudiesChronicAmino GroupActivated Partial Thromboplastin Time MeasurementBiologicalCoronaryCostDesignGlycosaminoglycansHospitalization
Grant awards (3)
Development of a covalent derivative of glycosamino glycans with oral anticoagula$13,566
R43 · FY2010 · HL · contact PI
Development of a covalent derivative of glycosamino glycans with oral anticoagula$149,900
R43 · FY2008 · HL · contact PI
ORAL ABSORBABLE LMW HEPARIN DERIVATIVES, IN VIVO STUDIES$99,858
R43 · FY2000 · HL